- Pathogenesis of Fabry nephropathy: The pathways leading to fibrosis
Paula Adriana Rozenfeld et al, 2020, Molecular Genetics and Metabolism CrossRef - EZH2 and KDM6B Expressions Are Associated with Specific Epigenetic Signatures during EMT in Non Small Cell Lung Carcinomas
Camille Lachat et al, 2020, Cancers CrossRef - The Large Phenotypic Spectrum of Fabry Disease Requires Graduated Diagnosis and Personalized Therapy: A Meta-Analysis Can Help to Differentiate Missense Mutations
Valentina Citro et al, 2016, International Journal of Molecular Sciences CrossRef - Accumulation of α-synuclein mediates podocyte injury in Fabry nephropathy
Fabian Braun et al, 2023, Journal of Clinical Investigation CrossRef - Icariin inhibits epithelial mesenchymal transition of renal tubular epithelial cells via regulating the miR-122-5p/FOXP2 axis in diabetic nephropathy rats
Li Zang et al, 2022, Journal of Pharmacological Sciences CrossRef - α‐Galactosidase A‐deficient rats accumulate glycosphingolipids and develop cardiorenal phenotypes of Fabry disease
James J. Miller et al, 2019, The FASEB Journal CrossRef - Therapeutic effects of icariin and icariside II on diabetes mellitus and its complications
Wei Jiang et al, 2023, Critical Reviews in Food Science and Nutrition CrossRef - The role of tubular cells in the pathogenesis of Fabry nephropathy
Paula Rozenfeld et al, 2024, Frontiers in Cardiovascular Medicine CrossRef - Signatures of Altered Gene Expression in Dorsal Root Ganglia of a Fabry Disease Mouse Model
Kai K. Kummer et al, 2018, Frontiers in Molecular Neuroscience CrossRef - ADAMTS6: Emerging roles in cardiovascular, musculoskeletal and cancer biology
Timothy J. Mead, 2022, Frontiers in Molecular Biosciences CrossRef - Lyso-glycosphingolipid abnormalities in different murine models of lysosomal storage disorders
Maria J. Ferraz et al, 2016, Molecular Genetics and Metabolism CrossRef